Company Filing History:
Years Active: 2013
Title: The Contributions of Holger Egger in the Field of Bacteriophage Technology
Introduction: Holger Egger, an innovative inventor based in Köln, Germany, has contributed significantly to the field of biotechnological advancements, particularly through his development of systems utilizing bacteriophages. With a keen interest in harnessing biological agents for practical applications, Egger's work stands out in the realm of pharmaceutical and therapeutic innovations.
Latest Patents: Holger Egger holds a patent for a unique system comprising bacteriophages and particles that contain active substances. His invention details a method in which a first additional peptide is fused to proteins of the bacteriophage. This first peptide adheres to the surface of a particle, while a second additional peptide can also be fused to the bacteriophage proteins, allowing it to attach to substrate surfaces. The innovation primarily aims for the delayed release of active agents and includes methodology for producing the system. Additionally, it presents a method for selecting phage species from a combinatorial phage population, showcasing Egger's innovative approach to biotechnology.
Career Highlights: Holger Egger is affiliated with Bayer Technology Services GmbH, where he has made remarkable strides in research and development. His patent not only underscores his expertise but also reflects the company’s commitment to advancing science and enhancing healthcare solutions.
Collaborations: Throughout his career, Holger has collaborated with esteemed colleagues, including Stefanie Eiden and Axel Eble. Working alongside such talented professionals has further enriched his research contributions and fostered an environment of innovation within their team.
Conclusion: Holger Egger is a notable inventor whose work with bacteriophages exemplifies a pioneering spirit in the field of biotechnology. His patented system not only advances scientific understanding but also opens new avenues for therapeutic applications. As a key player at Bayer Technology Services GmbH, Egger continues to push the boundaries of innovation, making significant impacts both in his field and the broader context of healthcare advancements.